MARMIROLI, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.724
AS - Asia 5.169
EU - Europa 4.448
SA - Sud America 650
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 131
OC - Oceania 40
Totale 25.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.460
SG - Singapore 1.853
GB - Regno Unito 1.716
CN - Cina 1.200
IT - Italia 734
HK - Hong Kong 629
VN - Vietnam 518
BR - Brasile 507
SE - Svezia 424
DE - Germania 345
FI - Finlandia 314
BD - Bangladesh 243
RU - Federazione Russa 201
FR - Francia 199
UA - Ucraina 193
KR - Corea 146
TR - Turchia 134
CA - Canada 108
IN - India 95
BG - Bulgaria 89
ID - Indonesia 66
AR - Argentina 47
MX - Messico 45
BE - Belgio 40
AU - Australia 38
IQ - Iraq 37
AE - Emirati Arabi Uniti 32
ZA - Sudafrica 32
IE - Irlanda 28
NL - Olanda 27
EC - Ecuador 25
IL - Israele 23
PK - Pakistan 23
CO - Colombia 22
JP - Giappone 22
MA - Marocco 20
CR - Costa Rica 19
PH - Filippine 18
PL - Polonia 17
AT - Austria 15
SA - Arabia Saudita 15
VE - Venezuela 15
CL - Cile 14
JM - Giamaica 14
NG - Nigeria 14
ES - Italia 13
GT - Guatemala 13
IR - Iran 13
LT - Lituania 13
MY - Malesia 13
RO - Romania 13
TT - Trinidad e Tobago 13
HN - Honduras 12
UZ - Uzbekistan 12
ET - Etiopia 11
NI - Nicaragua 9
QA - Qatar 9
TN - Tunisia 9
CW - ???statistics.table.value.countryCode.CW??? 8
EG - Egitto 8
PR - Porto Rico 8
AL - Albania 7
BY - Bielorussia 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 7
SC - Seychelles 7
SV - El Salvador 7
TH - Thailandia 7
BO - Bolivia 6
DZ - Algeria 6
NP - Nepal 6
OM - Oman 6
PT - Portogallo 6
TW - Taiwan 6
AZ - Azerbaigian 5
GE - Georgia 5
GP - Guadalupe 5
GR - Grecia 5
JO - Giordania 5
LB - Libano 5
NO - Norvegia 5
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
MD - Moldavia 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
HU - Ungheria 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 25.140
Salva come PNG Salva come JPEG
Città #
Ashburn 1.473
Southend 1.274
Singapore 1.228
Fairfield 1.216
Santa Clara 1.179
Woodbridge 734
San Jose 658
Hong Kong 616
Houston 542
Chicago 541
Chandler 519
Seattle 483
Wilmington 419
Council Bluffs 396
Cambridge 387
Jacksonville 371
Hefei 340
Los Angeles 340
Ann Arbor 327
Dearborn 315
Helsinki 242
London 231
Beijing 223
Nyköping 217
Salt Lake City 196
Ho Chi Minh City 176
San Diego 141
The Dalles 139
Modena 124
Hanoi 108
New York 105
Tampa 100
Seoul 98
Princeton 93
Dallas 92
Sofia 88
Elk Grove Village 87
Buffalo 76
Milan 73
Moscow 69
Eugene 68
Shanghai 68
Lauterbourg 61
Phoenix 61
Des Moines 59
Izmir 59
Bologna 55
Frankfurt am Main 52
Jakarta 52
Columbus 46
Lancaster 44
São Paulo 44
Boardman 43
Sterling 42
Atlanta 41
Dulles 38
Orem 38
Munich 37
Rome 33
Detroit 32
North Bergen 29
Haiphong 28
Miami 28
Redwood City 28
Grafing 26
Da Nang 25
Dublin 25
Fremont 22
Ghent 22
Pittsburgh 22
Brooklyn 21
Tokyo 20
Bremen 19
Chennai 19
Florence 19
Kansas City 19
Newark 19
Baghdad 18
Falls Church 18
Toronto 17
Montreal 16
Norwalk 16
Nuremberg 16
Rio de Janeiro 16
Las Vegas 15
San José 15
Jersey City 14
Naples 14
Redondo Beach 14
San Francisco 14
Brussels 13
Charlotte 13
Dong Ket 13
Guangzhou 13
Amsterdam 12
Johannesburg 12
Mexico City 12
Philadelphia 12
Boston 11
Brasília 11
Totale 17.725
Salva come PNG Salva come JPEG
Nome #
Development of solvent-casting particulate leaching (SCPL) polymer scaffolds as improved three-dimensional supports to mimic the bone marrow niche 520
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 500
The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression 484
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 462
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 461
MATER protein as substrate of PKCepsilon in human cumulus cells. 434
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins 429
Human MATER localization in specific cell domains of oocytes and follicular cells 423
Targeting of the Akt/PKB kinase to the actin skeleton 409
Ankrd2/ARPP is a novel Akt2 specific substrate andregulates myogenic differentiation upon cellular exposure to H(2)O(2). 399
AKT1-mediated Lamin A/C degradation is required for nuclear degradation and normal epidermal terminal differentiation 395
Risk Assessment for Metals and PAHs by Mediterranean Seafood 392
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells 389
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 387
Lamin A Ser404 Is a Nuclear Target of Akt Phosphorylation in C2C12 Cells 386
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 385
Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level 384
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 382
Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase 373
Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. 372
Cross-talk between the CK2 and AKT signaling pathways in cancer 369
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 354
Serum fatty acids and risk of cutaneous melanoma: a population-based case-control study 352
A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward 351
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 350
Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging 349
Phosphorylation, Signaling, and Cancer: Targets and Targeting 341
Troglitazione affects survival of human osteosarcoma cells 339
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 337
Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? 334
Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells 332
Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. 325
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 325
Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts 320
Inhibition of Ras-mediated signaling pathways in CML stem cells 309
The need for a reassessment of the safe upper limit of selenium in drinking water 308
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS. 304
Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth. 297
Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics 297
Reverse-phase protein microarrays (RPPA) as a diagnosticand therapeutic guide in multidrug resistant leukemia 290
New roles for lamins, nuclear envelope proteins and actin in the nucleus 285
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 282
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer 282
Clusterin enhances migration and invasion of prostate cancer cells through an isoform-specific Akt2/miR-190/PHLPP1 circuit. 281
Melanocytes – A novel tool to study mitochondrial dysfunction in Duchenne Muscular Dystrophy 279
Influence of selenium on the emergence of neuro tubule defects in a neuron-like cell line and its implications for amyotrophic lateral sclerosis 279
Signaling specificity in the Akt pathway in biology and disease 278
Nuclear damages and oxidative stress: new perspectives for laminopathies 274
Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity inBoth p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibitingthe Akt Pathway 273
Nuclear lipid-dependent signal transduction in human osteosarcoma cells. 272
Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies 266
Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy 266
Laminopathies and A-type lamin-associated signalling pathways 261
Nuclear PLCβ1 acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells 260
Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments. 256
Tiazofurin induces a down modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing. 252
At the nucleus of the problem: Nuclear proteins and disease 252
Phosphatidylinositol 3-kinase translocation to the nucleus is an early event in the interleukin-1 signalling mechanism in human osteosarcoma Saos-2 cells. 251
Age-related events in human active T limphocytes. Changes in the phosphoinositidase C activity. 243
Protein kinase B/AKT isoform 2 drives migration of human mesenchymal stem cells. 237
Phosphatidylinositol 3-kinase is recruited to a specific site in the activated IL-1 receptor I. 230
Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells. 229
Nuclear protein kinases in rat liver: evidence for increased Histone H1 phosphorylating activity during liver regeneration. 222
The key role of public health in renovating Italian biomedical doctoral programs 213
An unbiased approach to mapping the signaling network of the pseudorabies virus US3 protein 208
Transfected Saos-2 cells overexpressing phosphoinositidase C beta1 isoform accumulate it within the nucleus. 203
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 201
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence. 200
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 199
Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy. 197
The intranuclear amount of phospholipase C beta1 decreases following cell differentiation in Friend cells, whereas gamma1 isoform is not affected. 193
Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappa B transactivation in Saos2 cells requires the Akt/protein kinase B kinase 188
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 184
Interleukin-1alfa stimulates nuclear phosphoinositidase C activity in human osteosarcoma SaOS-2 cells. 177
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival 176
A different involvement of polyamines in the induction of tyrosine aminotransferase by glucagon, isoproterenol or serum in cultured heart cells 168
Study on the role of endogenous polyamines in glucagon, isoproterenol or serum-mediated induction of tyrosine aminotransferase in cultured heart cells 168
Mechanisms involved in the promoting activity of fibroblasts in HTLV-1-mediated lymphomagenesis: Insights into the plasticity of lymphomatous cells 161
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation 158
Involvement of thiol transferase- and thioredoxin-dependent systems in the protection of 'essential' thiol groups of ornithine decarboxylase 136
Editor's Note: Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway 135
Immunocytochemical detection of the specific association of different PIC isoforms with cytoskeletal and nuclear matrix compartments in PC12 cells 126
Stabilization of ornithine decarboxylase in erythroleukemia cells depleted of ATP 126
Effect of ATP depletion and phenanthroline on the spermidine-mediated decay of ornithine decarboxylase in erythroleukemia cells 125
IL-1 receptor signalling mechanism in SAOS-2 osteosarcoma cells 122
Effect of sodium arsentie on the induction and turnover of ornithine decarboxylase activity in erythroleukemia cells 121
Phosphorylation of ornithine decarboxylase in intact erythroleukemia cells 111
Inositol lipid phosphorylation and breakdown in rat liver nuclei is affected by hydrocortisone blood levels 104
Regulation of hormonal sensitivity of cardiac cells in culture by polyamines 101
Inhibition of rat heart ornithine decarboxylase by basic polypeptides 94
null 35
NFATc1 and NFATc2 regulate glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia through modulation of cholesterol biosynthesis and the WNT/β-catenin pathway 11
Totale 25.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.220 0 0 0 0 28 83 128 119 144 124 435 159
2022/20231.498 180 150 133 121 158 231 34 153 211 5 64 58
2023/20241.052 37 45 54 128 212 77 148 133 43 27 36 112
2024/20253.680 97 35 48 208 764 625 182 239 396 178 408 500
2025/20268.205 429 244 460 1.175 2.186 533 873 279 686 518 404 418
2026/20271.967 192 321 466 793 195 0 0 0 0 0 0 0
Totale 25.300